THE GLOBOCAN PROJECT
The aim of the project is to provide contemporary estimates of the incidence of, mortality, prevalence and disability-adjusted life years (DALYs) from major type of cancers, at national level, for 184 countries of the world. The GLOBOCAN estimates are presented for 2008, separately for each sex and, for incidence and mortality data, for ten age groups. 1-, 3- and 5-year prevalence data are available for the adult population only (ages 15 and over). DALYs, life years lost due to premature mortality (YLLs) and years lived with disability (YLDs) are available for all ages only. Please note that:
ClinicalTrials.gov - A service of the U.S. National Institutes of Health
Wykaz badań klinicznych
(ClinicalTrials.gov is a registry and results database of publicly and privately supported clinical studies of human participants conducted around the world.)
Zalecenia National Comprehensive Cancer Network
The National Comprehensive Cancer Network® (NCCN®) is an alliance of 23 of the world's leading cancer centers, working together to develop treatment guidelines for most cancers, and dedicated to research that improves the quality, effectiveness, and efficiency of cancer care. NCCN offers a number of programs to give clinicians access to tools and knowledge that can help guide decision-making in the management of cancer.
Zalecenia National Institute for Health and Clinical Excellence
What are the NICE 'referral advice' recommendations?
During the process of guidance development NICE's independent advisory bodies often give advice on referral from primary care to secondary care. At a workshop held in late 2009, it was suggested that referral advice should be made more accessible.
The NICE 'referral advice' recommendations database was created, and is maintained, by NICE's Accreditation and QIPP team.
What is in the NICE 'referral advice' recommendations database?
The NICE 'referral advice' recommendations database contains current primary-to-secondary referral advice from NICE clinical guidelines, cancer service guidance and public health guidance. The database replaces the NICE publication 'Referral Advice: A Guide to Appropriate Referral from Primary to Specialist Services' (December 2001).
Each record in the database contains the ‘referral advice' recommendation and includes additional information including the 'referral advice' category, health topic, the guidance it comes from (with a link to the relevant paragraph in the guidance) and the other 'referral advice' recommendations from the same guidance.
Zalecenia - American Society of Clinical Oncology (ASCO)
Guidelines can address specific clinical situations (disease-oriented) or use of approved medical products, procedures, or tests (modality-oriented). Using the best available evidence, ASCO expert panels identify and develop practice recommendations for specific areas of cancer care that would benefit from using practice guidelines.
Zalecenia European Society for Medical Oncology
The ESMO Clinical Practice Guidelines (CPG) are intended to provide oncology professionals with a set of recommendations for the best standards of cancer care, based on the findings of evidence-based medicine.
Each Clinical Practice Guideline includes information on the incidence of the malignancy, diagnostic criteria, staging of disease and risk assessment, treatment plans and follow-up.